Molecular genetics of microsatellite-unstable colorectal cancer for pathologists

Wei Chen, Benjamin J Swanson, Wendy L. Frankel

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

Background: Microsatellite-unstable colorectal cancers (CRC) that are due to deficient DNA mismatch repair (dMMR) represent approximately 15% of all CRCs in the United States. These microsatellite-unstable CRCs represent a heterogenous group of diseases with distinct oncogenesis pathways. There are overlapping clinicopathologic features between some of these groups, but many important differences are present. Therefore, determination of the etiology for the dMMR is vital for proper patient management and follow-up. Main body: Epigenetic inactivation of MLH1 MMR gene (sporadic microsatellite-unstable CRC) and germline mutation in an MMR gene (Lynch syndrome, LS) are the two most common mechanisms in the pathogenesis of microsatellite instability in CRC. However, in a subset of dMMR CRC cases that are identified by screening tests, no known LS-associated genetic alterations are appreciated by current genetic analysis. When the etiology for dMMR is unclear, it leads to patient anxiety and creates challenges for clinical management. Conclusion: It is critical to distinguish LS patients from other patients with tumors due to dMMR, so that the proper screening protocol can be employed for the patients and their families, with the goal to save lives while avoiding unnecessary anxiety and costs. This review summarizes the major pathogenesis pathways of dMMR CRCs, their clinicopathologic features, and practical screening suggestions. In addition, we include frequently asked questions for MMR immunohistochemistry interpretation.

Original languageEnglish (US)
Article number24
JournalDiagnostic Pathology
Volume12
Issue number1
DOIs
StatePublished - Mar 4 2017

Fingerprint

DNA Mismatch Repair
Microsatellite Repeats
Molecular Biology
Colorectal Neoplasms
Hereditary Nonpolyposis Colorectal Neoplasms
Anxiety
DNA Repair-Deficiency Disorders
Microsatellite Instability
Germ-Line Mutation
Epigenomics
Genes
Pathologists
Carcinogenesis
Immunohistochemistry
Costs and Cost Analysis
Neoplasms

Keywords

  • Colorectal cancer
  • Immunohistochemistry
  • Lynch syndrome
  • Microsatellite instability
  • Mismatch repair protein
  • MMR
  • Molecular genetics
  • MSI

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Molecular genetics of microsatellite-unstable colorectal cancer for pathologists. / Chen, Wei; Swanson, Benjamin J; Frankel, Wendy L.

In: Diagnostic Pathology, Vol. 12, No. 1, 24, 04.03.2017.

Research output: Contribution to journalReview article

@article{554fe9be89894004ba00a4d7a81c9eb0,
title = "Molecular genetics of microsatellite-unstable colorectal cancer for pathologists",
abstract = "Background: Microsatellite-unstable colorectal cancers (CRC) that are due to deficient DNA mismatch repair (dMMR) represent approximately 15{\%} of all CRCs in the United States. These microsatellite-unstable CRCs represent a heterogenous group of diseases with distinct oncogenesis pathways. There are overlapping clinicopathologic features between some of these groups, but many important differences are present. Therefore, determination of the etiology for the dMMR is vital for proper patient management and follow-up. Main body: Epigenetic inactivation of MLH1 MMR gene (sporadic microsatellite-unstable CRC) and germline mutation in an MMR gene (Lynch syndrome, LS) are the two most common mechanisms in the pathogenesis of microsatellite instability in CRC. However, in a subset of dMMR CRC cases that are identified by screening tests, no known LS-associated genetic alterations are appreciated by current genetic analysis. When the etiology for dMMR is unclear, it leads to patient anxiety and creates challenges for clinical management. Conclusion: It is critical to distinguish LS patients from other patients with tumors due to dMMR, so that the proper screening protocol can be employed for the patients and their families, with the goal to save lives while avoiding unnecessary anxiety and costs. This review summarizes the major pathogenesis pathways of dMMR CRCs, their clinicopathologic features, and practical screening suggestions. In addition, we include frequently asked questions for MMR immunohistochemistry interpretation.",
keywords = "Colorectal cancer, Immunohistochemistry, Lynch syndrome, Microsatellite instability, Mismatch repair protein, MMR, Molecular genetics, MSI",
author = "Wei Chen and Swanson, {Benjamin J} and Frankel, {Wendy L.}",
year = "2017",
month = "3",
day = "4",
doi = "10.1186/s13000-017-0613-8",
language = "English (US)",
volume = "12",
journal = "Diagnostic Pathology",
issn = "1746-1596",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Molecular genetics of microsatellite-unstable colorectal cancer for pathologists

AU - Chen, Wei

AU - Swanson, Benjamin J

AU - Frankel, Wendy L.

PY - 2017/3/4

Y1 - 2017/3/4

N2 - Background: Microsatellite-unstable colorectal cancers (CRC) that are due to deficient DNA mismatch repair (dMMR) represent approximately 15% of all CRCs in the United States. These microsatellite-unstable CRCs represent a heterogenous group of diseases with distinct oncogenesis pathways. There are overlapping clinicopathologic features between some of these groups, but many important differences are present. Therefore, determination of the etiology for the dMMR is vital for proper patient management and follow-up. Main body: Epigenetic inactivation of MLH1 MMR gene (sporadic microsatellite-unstable CRC) and germline mutation in an MMR gene (Lynch syndrome, LS) are the two most common mechanisms in the pathogenesis of microsatellite instability in CRC. However, in a subset of dMMR CRC cases that are identified by screening tests, no known LS-associated genetic alterations are appreciated by current genetic analysis. When the etiology for dMMR is unclear, it leads to patient anxiety and creates challenges for clinical management. Conclusion: It is critical to distinguish LS patients from other patients with tumors due to dMMR, so that the proper screening protocol can be employed for the patients and their families, with the goal to save lives while avoiding unnecessary anxiety and costs. This review summarizes the major pathogenesis pathways of dMMR CRCs, their clinicopathologic features, and practical screening suggestions. In addition, we include frequently asked questions for MMR immunohistochemistry interpretation.

AB - Background: Microsatellite-unstable colorectal cancers (CRC) that are due to deficient DNA mismatch repair (dMMR) represent approximately 15% of all CRCs in the United States. These microsatellite-unstable CRCs represent a heterogenous group of diseases with distinct oncogenesis pathways. There are overlapping clinicopathologic features between some of these groups, but many important differences are present. Therefore, determination of the etiology for the dMMR is vital for proper patient management and follow-up. Main body: Epigenetic inactivation of MLH1 MMR gene (sporadic microsatellite-unstable CRC) and germline mutation in an MMR gene (Lynch syndrome, LS) are the two most common mechanisms in the pathogenesis of microsatellite instability in CRC. However, in a subset of dMMR CRC cases that are identified by screening tests, no known LS-associated genetic alterations are appreciated by current genetic analysis. When the etiology for dMMR is unclear, it leads to patient anxiety and creates challenges for clinical management. Conclusion: It is critical to distinguish LS patients from other patients with tumors due to dMMR, so that the proper screening protocol can be employed for the patients and their families, with the goal to save lives while avoiding unnecessary anxiety and costs. This review summarizes the major pathogenesis pathways of dMMR CRCs, their clinicopathologic features, and practical screening suggestions. In addition, we include frequently asked questions for MMR immunohistochemistry interpretation.

KW - Colorectal cancer

KW - Immunohistochemistry

KW - Lynch syndrome

KW - Microsatellite instability

KW - Mismatch repair protein

KW - MMR

KW - Molecular genetics

KW - MSI

UR - http://www.scopus.com/inward/record.url?scp=85014387368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014387368&partnerID=8YFLogxK

U2 - 10.1186/s13000-017-0613-8

DO - 10.1186/s13000-017-0613-8

M3 - Review article

VL - 12

JO - Diagnostic Pathology

JF - Diagnostic Pathology

SN - 1746-1596

IS - 1

M1 - 24

ER -